Close

FBR Capital Starts Aegerion Pharmaceuticals (AEGR) at Outperform

October 30, 2013 7:58 AM EDT Send to a Friend
FBR Capital initiates coverage on Aegerion Pharmaceuticals (NASDAQ: AEGR) with a Outperform. PT $105.00.

Analyst William Tanner, Ph.D comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login